Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC3780 Nsc65847
Novel dual inhibitor of viral and Streptococcus pneumoniae neuraminidase
More description
DCC3779 Nsc-657186
Novel selective non-zinc-binding MMP-2 inhibitor
More description
DCC3778 Nsc636795
Novel inhibitor of ABCG2 transporter function
More description
DCC3777 Nsc-627757
Novel DNA repair inhibitor
More description
DCC3776 Nsc61610
Novel activator of lanthionine synthetase C-like 2 (LANCL2), down-modulating pulmonary inflammation through the downregulation of TNF-α and MCP-1 and reduction in the infiltration of neutrophils, accelerating recovery and inducing IL-10-mediated regulator
More description
DCC3775 Nsc-60339
Novel efflux pump inhibitor (EPI)
More description
DCC3774 Nsc57971
Novel non-peptide disruptor of IKKß/NEMO complex
More description
DCC3773 Nsc-57774
Novel potent SHP2 Inhibitor with Anti-Proliferative Activity in Breast Cancer Cell Lines
More description
DCC3772 Nsc-57148
Novel antagonist of the Grb7 SH2 domain; Antitumor Agent
More description
DCC3771 Nsc56452
Novel specific inhibitor of EGF receptor autophosphorylation and cell proliferation in HeLa cells by disrupting allosteric activation of EGF-stimulated dimer
More description
DCC3770 Nsc-55158
Novel antagonist of the Grb7 SH2 domain; Antitumor Agent
More description
DCC3769 Nsc52101
Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein
More description
DCC3768 nsc48693 Dihydrochloride
Potent apoptosis inducer in pancreatic cancer cells
More description
DCC3767 Nsc-4231
Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity
More description
DCC3766 Nsc-347518
DT-diaphorase inhibitor
More description
DCC3765 Nsc339614 Potassium Salt
Selective potentiator at GluN1/GluN2C and GluN1/GluN2D receptors
More description
DCC3764 Nsc-339579
Novel potent Mycobacterium tuberculosis DHFR inhibitor
More description
DCC3763 Nsc-33353
Potent inhibitor of the AcrAB-TolC efflux pump in Escherichia coli, potentiating the antibacterial activities of novobiocin and erythromycin upon binding to the membrane fusion protein AcrA
More description
DCC3762 Nsc-311068
Novel selective inhibitor of TET1 transcription and 5-hydroxymethylcytosine (5hmC) modification, effectively inhibiting cell viability in AML with high expression of TET1
More description
DCC3761 Nsc30049
Novel inhibitor of Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations
More description
DCC3760 Nsc-299202
Novel potent gonist of Human G Protein-Coupled Receptor-35 (hGPR35) (EC50 8 nM)
More description
DCC3759 Nsc-2888
Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity
More description
DCC3758 Nsc-279287
Novel Inhibitor of the p53-mdm2 Interaction, Activating p53-Dependent Transcription in mdm2-Overexpressing Cells
More description
DCC3757 Nsc265473
Novel substrate of ABCG2
More description
DCC3756 nsc-252359
Specific Ligand for Stem Loop 3 Ribonucleic Acid of the Packaging Signal Ψ of Human Immunodeficiency Virus-1
More description
DCC3755 Nsc-2488 [5459-61-0]
Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity
More description
DCC3754 Nsc24674
Novel 3C-like protease inhibitor of SARS-CoV-2
More description
DCC3753 Nsc-24198
Novel potent SHP2 Inhibitor with Anti-Proliferative Activity in Breast Cancer Cell Lines
More description
DCC3752 Nsc24048
Novel inhibitor of ABCG2 transporter function
More description
DCC3751 nsc-20596
Capturer of kinase-insertion domain receptor (KDR) from a solution, while allowing the captured KDR to bind with the solution-phase vascular endothelial growth factor (VEGF)
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X